MedPath

Effect of Diphenhydramine Compound in Covid-19

Phase 3
Recruiting
Conditions
Covid-19.
virus identified’ is assigned to a disease diagnosis of COVID-19 confirmed by laboratory testing.
U07.1
Registration Number
IRCT20200504047298N3
Lead Sponsor
Karaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Confirmed Covid-19 Infection
Age between 18_70 years old

Exclusion Criteria

Cardiovascular disease
non confirmed patients
Addicted patient

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of involment of lung in HRCT(High-resolution computed tomography). Timepoint: Day 0 and 7 Days later. Method of measurement: HRCT(High-resolution computed tomography).;Change of viral load in Real Time PCR. Timepoint: Day 0 and 7 days later. Method of measurement: Real Time PCR nasopharengeal soap.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath